| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
31,652 |
30,317 |
$9.48M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
6,996 |
6,625 |
$7.41M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
27,862 |
25,078 |
$5.19M |
| J9271 |
Injection, pembrolizumab, 1 mg |
848 |
618 |
$5.01M |
| OP279 |
|
25,790 |
23,454 |
$4.74M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
21,414 |
12,917 |
$3.97M |
| 93017 |
|
20,002 |
18,935 |
$3.39M |
| OP278 |
|
1,659 |
1,487 |
$3.28M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13,143 |
12,343 |
$2.78M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,462 |
12,772 |
$2.68M |
| 80053 |
Comprehensive metabolic panel |
201,758 |
180,418 |
$2.51M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,521 |
7,994 |
$2.35M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
10,989 |
10,337 |
$2.14M |
| OP710 |
|
23,710 |
21,666 |
$2.10M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
9,083 |
5,189 |
$2.07M |
| G0378 |
Hospital observation service, per hour |
3,153 |
2,474 |
$1.87M |
| 84443 |
Thyroid stimulating hormone (TSH) |
86,229 |
83,531 |
$1.83M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,063 |
13,069 |
$1.73M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
17,846 |
16,627 |
$1.72M |
| 80061 |
Lipid panel |
94,285 |
91,603 |
$1.53M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
2,860 |
2,682 |
$1.50M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
203,328 |
177,288 |
$1.37M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,296 |
1,202 |
$1.33M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,151 |
11,678 |
$1.31M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
3,502 |
3,194 |
$1.27M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
16,420 |
16,012 |
$1.22M |
| 93970 |
|
5,260 |
5,010 |
$1.22M |
| 93458 |
|
812 |
742 |
$1.13M |
| OP379 |
|
25,031 |
22,630 |
$1.03M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
514 |
362 |
$971K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
557 |
358 |
$941K |
| J2785 |
Injection, regadenoson, 0.1 mg |
8,172 |
7,618 |
$917K |
| OP259 |
|
73,379 |
50,357 |
$891K |
| 76641 |
|
11,547 |
9,583 |
$868K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
5,379 |
4,332 |
$837K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
4,727 |
2,754 |
$817K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,956 |
1,821 |
$805K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
1,052 |
691 |
$797K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
486 |
333 |
$757K |
| 96417 |
|
2,671 |
1,728 |
$757K |
| 10005 |
|
2,417 |
2,267 |
$747K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
17,142 |
15,850 |
$722K |
| J0897 |
Injection, denosumab, 1 mg |
705 |
643 |
$721K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16,398 |
15,728 |
$702K |
| 93880 |
|
6,004 |
5,683 |
$699K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
14,780 |
13,498 |
$686K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
6,622 |
5,887 |
$685K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
10,724 |
10,215 |
$666K |
| 93925 |
|
4,790 |
4,542 |
$661K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,372 |
2,223 |
$661K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
6,489 |
6,185 |
$619K |
| 76830 |
Ultrasound, transvaginal |
5,069 |
4,908 |
$606K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16,477 |
16,312 |
$603K |
| 76536 |
|
6,457 |
6,237 |
$600K |
| 93226 |
|
2,939 |
2,828 |
$591K |
| 75574 |
|
1,274 |
1,223 |
$588K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
5,091 |
2,668 |
$558K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
69,152 |
67,074 |
$547K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,987 |
3,785 |
$526K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,411 |
2,270 |
$526K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,238 |
2,093 |
$509K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,270 |
2,128 |
$492K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13,789 |
13,280 |
$457K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19,785 |
17,540 |
$457K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,516 |
11,317 |
$448K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,647 |
1,056 |
$439K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
12,777 |
11,522 |
$438K |
| 93971 |
|
2,621 |
2,471 |
$419K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,974 |
6,196 |
$416K |
| 86235 |
|
3,222 |
2,675 |
$413K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,114 |
2,919 |
$400K |
| 84439 |
|
37,096 |
35,956 |
$399K |
| 93225 |
|
2,910 |
2,806 |
$396K |
| 77080 |
|
6,291 |
5,968 |
$390K |
| 86803 |
|
21,006 |
20,391 |
$387K |
| 95806 |
|
131 |
129 |
$385K |
| 59025 |
Fetal non-stress test |
2,218 |
1,831 |
$382K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
2,158 |
1,969 |
$373K |
| 77412 |
|
3,945 |
345 |
$368K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13,638 |
9,001 |
$365K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
1,890 |
1,692 |
$365K |
| J1756 |
Injection, iron sucrose, 1 mg |
8,484 |
3,152 |
$359K |
| 62323 |
|
564 |
499 |
$355K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,179 |
5,671 |
$355K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,318 |
2,742 |
$355K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
3,964 |
2,585 |
$337K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,521 |
4,358 |
$333K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
10,610 |
3,051 |
$328K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,002 |
939 |
$323K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,576 |
1,526 |
$318K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
16,600 |
14,011 |
$316K |
| 88173 |
|
3,465 |
3,289 |
$307K |
| 87481 |
|
4,447 |
4,224 |
$303K |
| J9395 |
Injection, fulvestrant, 25 mg |
310 |
253 |
$291K |
| 88312 |
|
6,982 |
6,660 |
$290K |
| J9045 |
Injection, carboplatin, 50 mg |
568 |
369 |
$290K |
| 72197 |
|
773 |
694 |
$287K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
15,608 |
4,145 |
$284K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
5,190 |
4,969 |
$282K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
25,535 |
21,821 |
$280K |
| 71046 |
Radiologic examination, chest; 2 views |
14,552 |
13,726 |
$266K |
| 64483 |
|
252 |
235 |
$265K |
| 84480 |
|
15,989 |
15,476 |
$261K |
| 99234 |
|
1,829 |
1,501 |
$259K |
| 74183 |
|
711 |
662 |
$258K |
| 77049 |
|
749 |
722 |
$257K |
| 73221 |
|
889 |
830 |
$246K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
9,526 |
9,218 |
$236K |
| 82728 |
|
23,518 |
21,767 |
$236K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
37,889 |
33,583 |
$236K |
| 83883 |
|
2,634 |
2,493 |
$232K |
| 96411 |
|
1,202 |
717 |
$231K |
| 76801 |
|
2,209 |
2,010 |
$231K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
91 |
83 |
$230K |
| 77066 |
Tomosynthesis, mammo |
2,639 |
2,547 |
$216K |
| 93978 |
|
1,460 |
1,377 |
$207K |
| 71250 |
|
2,822 |
2,602 |
$204K |
| 77065 |
Tomosynthesis, mammo |
4,224 |
4,006 |
$202K |
| 81003 |
|
57,019 |
53,898 |
$201K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
10,018 |
9,677 |
$201K |
| 87899 |
|
12,794 |
12,420 |
$200K |
| 72141 |
|
877 |
816 |
$197K |
| 81001 |
|
45,047 |
40,698 |
$190K |
| 96376 |
|
3,073 |
2,119 |
$189K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
931 |
790 |
$183K |
| 93922 |
|
2,840 |
2,687 |
$182K |
| 86480 |
|
3,677 |
3,539 |
$179K |
| 86003 |
|
491 |
470 |
$179K |
| 72110 |
|
3,072 |
2,911 |
$172K |
| 76770 |
|
2,359 |
2,254 |
$167K |
| 73564 |
|
4,621 |
3,932 |
$165K |
| 96415 |
|
1,826 |
1,154 |
$164K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
107 |
102 |
$161K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
590 |
531 |
$160K |
| J9267 |
Injection, paclitaxel, 1 mg |
138 |
63 |
$160K |
| 82607 |
|
13,795 |
13,051 |
$159K |
| 96416 |
|
512 |
277 |
$156K |
| 88307 |
|
1,856 |
1,641 |
$155K |
| 88304 |
|
3,625 |
3,335 |
$152K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
5,457 |
5,183 |
$150K |
| 82378 |
|
8,514 |
7,356 |
$147K |
| 77091 |
|
2,554 |
2,371 |
$143K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,083 |
3,884 |
$138K |
| 93923 |
|
1,564 |
1,471 |
$137K |
| 96402 |
|
1,376 |
1,182 |
$135K |
| 82043 |
|
23,672 |
23,046 |
$132K |
| 70486 |
|
1,100 |
1,062 |
$130K |
| 83550 |
|
25,836 |
24,033 |
$129K |
| 86618 |
|
2,086 |
2,012 |
$129K |
| 86769 |
|
4,950 |
4,470 |
$127K |
| 36415 |
Collection of venous blood by venipuncture |
79,567 |
68,676 |
$127K |
| 86300 |
|
4,143 |
3,776 |
$124K |
| 97161 |
|
1,969 |
1,847 |
$122K |
| 83970 |
|
4,030 |
3,827 |
$122K |
| 76813 |
|
1,032 |
1,007 |
$122K |
| C1760 |
Closure device, vascular (implantable/insertable) |
1,041 |
918 |
$118K |
| 87536 |
|
1,056 |
1,029 |
$116K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
457 |
426 |
$115K |
| A4648 |
Tissue marker, implantable, any type, each |
864 |
731 |
$115K |
| 84146 |
|
3,850 |
3,680 |
$113K |
| 86200 |
|
3,716 |
3,341 |
$113K |
| 84153 |
|
6,837 |
6,382 |
$112K |
| 88172 |
|
3,413 |
3,228 |
$111K |
| 77336 |
|
1,682 |
677 |
$110K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
15,996 |
13,031 |
$109K |
| 84402 |
|
2,506 |
2,430 |
$108K |
| 73630 |
|
3,506 |
2,978 |
$107K |
| 47562 |
|
95 |
91 |
$107K |
| A0425 |
Ground mileage, per statute mile |
10,564 |
8,425 |
$106K |
| 87340 |
|
7,982 |
7,649 |
$106K |
| 82670 |
|
2,773 |
2,694 |
$105K |
| 88185 |
|
545 |
517 |
$105K |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
126 |
77 |
$105K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
966 |
871 |
$104K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
165 |
153 |
$103K |
| 86147 |
|
1,858 |
1,251 |
$102K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
5,825 |
5,396 |
$101K |
| 82652 |
|
2,177 |
2,148 |
$101K |
| 84403 |
|
2,865 |
2,783 |
$99K |
| 83001 |
|
3,725 |
3,627 |
$97K |
| 73130 |
|
2,728 |
2,287 |
$97K |
| 82627 |
|
2,185 |
2,116 |
$96K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,494 |
1,348 |
$94K |
| 71045 |
Radiologic examination, chest; single view |
8,692 |
7,838 |
$94K |
| C1769 |
Guide wire |
1,771 |
1,458 |
$92K |
| 86696 |
|
2,722 |
2,623 |
$92K |
| 86038 |
|
7,349 |
6,962 |
$91K |
| 83540 |
|
26,633 |
24,799 |
$91K |
| 83002 |
|
3,469 |
3,384 |
$90K |
| 77387 |
|
2,268 |
240 |
$89K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
798 |
659 |
$86K |
| 82746 |
|
6,688 |
6,440 |
$86K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,248 |
1,184 |
$85K |
| 96367 |
|
3,420 |
2,334 |
$83K |
| 86706 |
|
5,884 |
5,714 |
$82K |
| 80076 |
|
12,125 |
11,363 |
$81K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,198 |
1,733 |
$81K |
| 87184 |
|
6,972 |
6,497 |
$79K |
| 87070 |
|
7,646 |
7,236 |
$79K |
| 73030 |
|
3,107 |
2,826 |
$78K |
| 77334 |
|
585 |
368 |
$78K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
11,540 |
10,481 |
$76K |
| 74246 |
|
462 |
447 |
$75K |
| 74178 |
|
212 |
202 |
$74K |
| 87088 |
|
24,017 |
22,489 |
$74K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
967 |
844 |
$74K |
| 86703 |
|
3,993 |
3,896 |
$74K |
| 86140 |
|
12,874 |
12,323 |
$73K |
| 84484 |
|
10,692 |
9,147 |
$72K |
| 73610 |
|
2,432 |
2,152 |
$71K |
| 82570 |
|
25,600 |
24,740 |
$69K |
| 76981 |
|
303 |
289 |
$68K |
| C1874 |
Stent, coated/covered, with delivery system |
74 |
67 |
$68K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,535 |
1,395 |
$67K |
| 72052 |
|
949 |
916 |
$67K |
| 83690 |
|
14,712 |
13,473 |
$67K |
| 0002A |
|
2,741 |
2,729 |
$66K |
| 85610 |
|
18,091 |
14,753 |
$65K |
| 83880 |
|
4,319 |
3,998 |
$65K |
| 84425 |
|
1,789 |
1,743 |
$64K |
| 86800 |
|
4,035 |
3,906 |
$63K |
| 81025 |
|
7,551 |
6,659 |
$63K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
57 |
52 |
$62K |
| 86431 |
|
7,735 |
6,820 |
$62K |
| 70491 |
|
324 |
309 |
$61K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,123 |
975 |
$61K |
| 82550 |
|
10,979 |
9,861 |
$61K |
| 97803 |
|
1,865 |
1,774 |
$61K |
| 0001A |
|
2,764 |
2,750 |
$61K |
| J0875 |
Injection, dalbavancin, 5 mg |
17 |
12 |
$61K |
| 86704 |
|
4,152 |
4,006 |
$60K |
| 87634 |
|
1,533 |
1,467 |
$58K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,688 |
2,577 |
$58K |
| 86146 |
|
1,802 |
1,188 |
$58K |
| 84481 |
|
3,252 |
3,120 |
$57K |
| 80074 |
|
1,574 |
1,524 |
$57K |
| 93976 |
|
305 |
289 |
$57K |
| 93312 |
|
268 |
221 |
$56K |
| 86376 |
|
4,724 |
4,586 |
$55K |
| 83735 |
|
18,887 |
15,385 |
$55K |
| 82784 |
|
3,476 |
3,192 |
$54K |
| 52000 |
|
425 |
396 |
$53K |
| 73110 |
|
1,520 |
1,315 |
$53K |
| 86695 |
|
2,713 |
2,613 |
$53K |
| 87799 |
|
477 |
442 |
$52K |
| 30140 |
|
28 |
26 |
$52K |
| 84550 |
|
11,004 |
10,484 |
$51K |
| 83520 |
|
3,293 |
2,950 |
$50K |
| 71271 |
|
709 |
675 |
$49K |
| 84445 |
|
1,647 |
1,601 |
$48K |
| 83921 |
|
2,981 |
2,872 |
$48K |
| 87077 |
|
9,067 |
8,498 |
$48K |
| 64493 |
|
27 |
27 |
$47K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
2,449 |
1,999 |
$46K |
| 86850 |
|
7,516 |
6,573 |
$46K |
| 83516 |
|
2,161 |
1,782 |
$45K |
| 85730 |
|
11,421 |
10,266 |
$43K |
| 74019 |
|
1,251 |
1,171 |
$42K |
| 87521 |
Neg quan hep c or qual rna |
958 |
902 |
$41K |
| 88184 |
|
570 |
539 |
$41K |
| 86255 |
|
2,531 |
2,464 |
$40K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
559 |
287 |
$40K |
| 85652 |
|
16,177 |
15,595 |
$40K |
| OP229 |
|
772 |
713 |
$39K |
| 83498 |
|
929 |
904 |
$39K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,497 |
940 |
$39K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
463 |
424 |
$39K |
| 86735 |
|
1,621 |
1,588 |
$39K |
| 97802 |
|
589 |
579 |
$39K |
| 83615 |
|
9,394 |
8,394 |
$38K |
| 86225 |
|
2,171 |
1,969 |
$38K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,402 |
6,598 |
$38K |
| 82172 |
|
2,031 |
1,976 |
$37K |
| 10022 |
|
306 |
275 |
$37K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
316 |
310 |
$37K |
| 86039 |
|
2,355 |
2,184 |
$36K |
| 86762 |
|
2,551 |
2,456 |
$36K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,454 |
1,152 |
$35K |
| 72131 |
|
742 |
675 |
$35K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
626 |
519 |
$35K |
| 83010 |
|
1,621 |
1,558 |
$35K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
110 |
50 |
$34K |
| 93975 |
|
164 |
155 |
$34K |
| 86592 |
|
11,031 |
10,698 |
$33K |
| 87506 |
|
287 |
272 |
$33K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
12 |
12 |
$32K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13,279 |
10,504 |
$31K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
211 |
182 |
$29K |
| 73502 |
|
1,845 |
1,583 |
$29K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13,495 |
11,376 |
$29K |
| 82533 |
|
1,923 |
1,724 |
$29K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,320 |
1,667 |
$28K |
| 83021 |
|
1,485 |
1,408 |
$27K |
| 82330 |
|
898 |
834 |
$27K |
| 86765 |
|
2,388 |
2,296 |
$27K |
| 87486 |
|
1,046 |
992 |
$27K |
| 86787 |
|
1,308 |
1,265 |
$27K |
| 85027 |
|
6,323 |
5,787 |
$27K |
| 87581 |
|
1,046 |
992 |
$27K |
| 83605 |
|
4,355 |
3,849 |
$26K |
| 82962 |
|
7,138 |
4,975 |
$26K |
| OP258 |
|
16,741 |
12,907 |
$26K |
| 93308 |
|
137 |
132 |
$25K |
| 87430 |
|
2,144 |
2,109 |
$25K |
| 82977 |
|
2,857 |
2,705 |
$25K |
| 86901 |
|
7,608 |
6,630 |
$24K |
| 94060 |
|
256 |
221 |
$24K |
| 82553 |
|
4,931 |
4,389 |
$23K |
| 87040 |
|
3,138 |
2,825 |
$23K |
| 74174 |
|
107 |
95 |
$23K |
| 86160 |
|
1,267 |
1,190 |
$23K |
| 88187 |
|
256 |
249 |
$22K |
| 86334 |
|
1,271 |
1,204 |
$21K |
| 84702 |
|
1,748 |
1,442 |
$20K |
| 96377 |
|
698 |
465 |
$20K |
| 83525 |
|
1,545 |
1,497 |
$19K |
| 82024 |
|
499 |
475 |
$19K |
| 87517 |
|
465 |
441 |
$19K |
| 86900 |
|
7,521 |
6,599 |
$19K |
| 84100 |
|
8,890 |
7,695 |
$18K |
| 19081 |
|
29 |
27 |
$18K |
| 97162 |
|
209 |
206 |
$18K |
| 84144 |
|
509 |
484 |
$18K |
| 83993 |
|
507 |
488 |
$18K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
380 |
180 |
$18K |
| 84134 |
|
1,073 |
1,047 |
$18K |
| 85045 |
|
8,462 |
7,661 |
$17K |
| 87512 |
|
470 |
437 |
$17K |
| 76857 |
|
768 |
721 |
$17K |
| 76942 |
|
293 |
274 |
$16K |
| 84165 |
|
3,001 |
2,844 |
$16K |
| 76870 |
|
243 |
230 |
$16K |
| 74018 |
|
494 |
458 |
$15K |
| 82157 |
|
346 |
333 |
$15K |
| C1768 |
Graft, vascular |
13 |
12 |
$15K |
| 82150 |
|
1,947 |
1,873 |
$15K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,803 |
2,174 |
$14K |
| C1732 |
Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping |
17 |
12 |
$13K |
| 85378 |
|
3,281 |
3,149 |
$13K |
| 84681 |
|
595 |
567 |
$13K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
479 |
404 |
$13K |
| 0004A |
|
531 |
516 |
$13K |
| 86304 |
|
963 |
672 |
$12K |
| 84154 |
|
1,142 |
1,116 |
$12K |
| 10021 |
|
345 |
326 |
$12K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
474 |
133 |
$12K |
| 88108 |
|
648 |
564 |
$12K |
| 77300 |
|
164 |
127 |
$12K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
30 |
27 |
$11K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
676 |
587 |
$11K |
| 82985 |
|
1,619 |
1,551 |
$11K |
| C9600 |
Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
35 |
26 |
$11K |
| 82397 |
|
454 |
440 |
$11K |
| 82105 |
|
739 |
705 |
$10K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
273 |
226 |
$10K |
| 86361 |
|
472 |
461 |
$10K |
| 87081 |
|
1,072 |
999 |
$10K |
| 83721 |
|
1,757 |
1,713 |
$9K |
| 82274 |
|
1,146 |
1,129 |
$9K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,643 |
973 |
$9K |
| 94760 |
|
1,219 |
956 |
$9K |
| 88142 |
|
256 |
256 |
$9K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
127 |
115 |
$9K |
| 73080 |
|
306 |
278 |
$9K |
| 82166 |
|
235 |
218 |
$9K |
| 84478 |
|
1,011 |
983 |
$9K |
| 70498 |
|
43 |
41 |
$8K |
| 72100 |
|
255 |
242 |
$8K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
811 |
662 |
$8K |
| 86021 |
|
197 |
191 |
$8K |
| 84432 |
|
468 |
444 |
$8K |
| 86256 |
|
559 |
529 |
$8K |
| 0011A |
|
362 |
360 |
$8K |
| 82232 |
|
843 |
776 |
$8K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,299 |
729 |
$8K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
245 |
237 |
$8K |
| 90715 |
|
490 |
456 |
$8K |
| 82247 |
|
2,302 |
1,991 |
$8K |
| 80320 |
|
1,166 |
1,072 |
$7K |
| 36591 |
|
237 |
174 |
$7K |
| 0012A |
|
263 |
262 |
$7K |
| 94729 |
|
377 |
304 |
$7K |
| 84630 |
|
466 |
460 |
$7K |
| 84305 |
|
295 |
287 |
$7K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
58 |
33 |
$7K |
| 72170 |
|
352 |
308 |
$7K |
| 96523 |
|
210 |
151 |
$7K |
| 88313 |
|
238 |
193 |
$7K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
105 |
104 |
$7K |
| 86364 |
|
565 |
296 |
$7K |
| 93351 |
|
39 |
39 |
$7K |
| J9190 |
Injection, fluorouracil, 500 mg |
853 |
331 |
$7K |
| 90870 |
|
38 |
12 |
$6K |
| 80050 |
General health panel |
176 |
174 |
$6K |
| 96368 |
|
57 |
40 |
$6K |
| 87529 |
|
102 |
91 |
$6K |
| 87338 |
|
680 |
671 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
297 |
283 |
$6K |
| 76000 |
|
693 |
631 |
$6K |
| 83695 |
|
662 |
648 |
$6K |
| 84460 |
|
1,693 |
1,596 |
$6K |
| 84450 |
|
1,664 |
1,567 |
$5K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
47 |
37 |
$5K |
| 82465 |
|
1,017 |
989 |
$5K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
335 |
178 |
$5K |
| 78306 |
|
79 |
74 |
$5K |
| 88311 |
|
762 |
684 |
$5K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
28 |
28 |
$5K |
| 84703 |
|
714 |
670 |
$5K |
| 82947 |
|
1,332 |
1,234 |
$5K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,880 |
2,959 |
$5K |
| 86430 |
|
782 |
780 |
$5K |
| 86481 |
|
86 |
86 |
$5K |
| 82088 |
|
120 |
112 |
$5K |
| 93798 |
|
230 |
24 |
$5K |
| 0003A |
|
213 |
212 |
$5K |
| 76775 |
|
103 |
98 |
$5K |
| 72070 |
|
117 |
112 |
$5K |
| 88342 |
|
131 |
105 |
$4K |
| 86340 |
|
183 |
176 |
$4K |
| 81490 |
|
12 |
12 |
$4K |
| 84166 |
|
289 |
281 |
$4K |
| 82565 |
|
856 |
794 |
$4K |
| 80299 |
|
488 |
450 |
$4K |
| 80143 |
|
428 |
382 |
$4K |
| 82785 |
|
236 |
228 |
$4K |
| 80179 |
|
784 |
698 |
$4K |
| 77280 |
|
58 |
50 |
$4K |
| 29125 |
|
67 |
61 |
$4K |
| 75635 |
|
40 |
38 |
$4K |
| 97165 |
|
99 |
80 |
$4K |
| 93990 |
|
25 |
25 |
$4K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
6,819 |
4,773 |
$4K |
| 87147 |
|
742 |
720 |
$3K |
| 77003 |
|
947 |
892 |
$3K |
| 84156 |
|
1,291 |
1,212 |
$3K |
| 82787 |
|
55 |
49 |
$3K |
| 77417 |
|
172 |
78 |
$3K |
| 73140 |
|
118 |
114 |
$3K |
| 73718 |
|
15 |
12 |
$3K |
| 12001 |
|
25 |
24 |
$3K |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
19 |
13 |
$3K |
| 87625 |
|
302 |
253 |
$3K |
| 0064A |
|
114 |
113 |
$3K |
| 93926 |
|
44 |
38 |
$3K |
| 84520 |
|
664 |
622 |
$3K |
| 82950 |
|
775 |
749 |
$3K |
| 85613 |
|
231 |
221 |
$3K |
| 0071A |
|
105 |
104 |
$3K |
| 80177 |
|
124 |
121 |
$3K |
| 87209 |
|
291 |
279 |
$3K |
| 86341 |
|
39 |
30 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
47 |
47 |
$3K |
| 84244 |
|
90 |
84 |
$3K |
| 86335 |
|
106 |
99 |
$2K |
| 74240 |
|
12 |
12 |
$2K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
21 |
19 |
$2K |
| 0124A |
|
120 |
103 |
$2K |
| 88341 |
|
31 |
24 |
$2K |
| 88302 |
|
116 |
102 |
$2K |
| 0072A |
|
92 |
92 |
$2K |
| 86708 |
|
125 |
121 |
$2K |
| 81050 |
|
402 |
372 |
$2K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
16 |
16 |
$2K |
| 29515 |
|
40 |
39 |
$2K |
| 87324 |
|
642 |
586 |
$2K |
| 73590 |
|
90 |
80 |
$2K |
| 74220 |
|
95 |
90 |
$2K |
| 74021 |
|
66 |
64 |
$2K |
| 73560 |
|
81 |
71 |
$2K |
| 84436 |
|
473 |
461 |
$2K |
| 87177 |
|
291 |
279 |
$2K |
| 82656 |
|
106 |
101 |
$2K |
| 86148 |
|
96 |
89 |
$2K |
| 71100 |
|
68 |
64 |
$2K |
| 85041 |
|
1,498 |
1,365 |
$1K |
| 86617 |
|
28 |
27 |
$1K |
| 85384 |
|
170 |
144 |
$1K |
| 96409 |
|
29 |
15 |
$1K |
| 85014 |
|
1,703 |
1,529 |
$1K |
| 84235 |
|
32 |
32 |
$1K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
37 |
24 |
$1K |
| 73700 |
|
13 |
13 |
$1K |
| OP276 |
|
28 |
25 |
$1K |
| 85018 |
|
1,621 |
1,468 |
$1K |
| 82164 |
|
45 |
43 |
$1K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,681 |
989 |
$1K |
| 83835 |
|
100 |
93 |
$1K |
| 70480 |
|
14 |
12 |
$1K |
| 83519 |
|
29 |
25 |
$1K |
| 84270 |
|
51 |
50 |
$1K |
| 72050 |
|
15 |
13 |
$1K |
| 94726 |
|
70 |
54 |
$1K |
| 93613 |
|
17 |
12 |
$1K |
| 86329 |
|
81 |
79 |
$1K |
| 80069 |
|
243 |
220 |
$1K |
| 94727 |
|
61 |
55 |
$1K |
| 86774 |
|
72 |
69 |
$955.47 |
| 86709 |
|
62 |
62 |
$951.46 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
1,256 |
1,159 |
$945.10 |
| 82248 |
|
117 |
85 |
$936.55 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,059 |
1,839 |
$928.88 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
46 |
43 |
$926.64 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
13 |
12 |
$924.76 |
| 84590 |
|
55 |
55 |
$863.11 |
| 84482 |
|
29 |
29 |
$863.07 |
| 87420 |
|
60 |
59 |
$848.41 |
| 85303 |
|
42 |
40 |
$842.57 |
| J1741 |
Injection, ibuprofen, 100 mg |
73 |
62 |
$817.32 |
| 87563 |
|
45 |
44 |
$806.23 |
| 36430 |
|
14 |
13 |
$786.34 |
| 83704 |
|
30 |
28 |
$785.89 |
| A9581 |
Injection, gadoxetate disodium, 1 ml |
30 |
27 |
$782.87 |
| 76098 |
|
55 |
52 |
$761.96 |
| 87045 |
|
78 |
74 |
$703.26 |
| 72082 |
|
13 |
12 |
$608.34 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
76 |
62 |
$553.70 |
| 82085 |
|
39 |
38 |
$525.04 |
| J2060 |
Injection, lorazepam, 2 mg |
367 |
298 |
$523.09 |
| 86780 |
|
37 |
36 |
$504.87 |
| 87205 |
|
71 |
66 |
$496.16 |
| 82668 |
|
55 |
50 |
$492.69 |
| 75571 |
|
338 |
308 |
$477.94 |
| 82310 |
|
111 |
88 |
$413.75 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
32 |
31 |
$397.77 |
| 80164 |
|
54 |
50 |
$392.25 |
| 36416 |
|
169 |
107 |
$350.54 |
| 87046 |
|
91 |
87 |
$350.10 |
| 85576 |
|
16 |
15 |
$333.45 |
| 87075 |
|
64 |
48 |
$302.65 |
| 84132 |
|
275 |
230 |
$289.96 |
| 86615 |
|
13 |
12 |
$279.36 |
| 88300 |
|
32 |
27 |
$263.18 |
| 82040 |
|
646 |
590 |
$246.56 |
| 85300 |
|
15 |
14 |
$233.52 |
| 86705 |
|
15 |
15 |
$232.08 |
| 87185 |
|
48 |
39 |
$169.86 |
| J3360 |
Injection, diazepam, up to 5 mg |
12 |
12 |
$154.50 |
| 87341 |
|
13 |
12 |
$146.28 |
| 82803 |
|
15 |
12 |
$143.16 |
| 86593 |
|
28 |
28 |
$137.53 |
| 77081 |
|
13 |
12 |
$127.96 |
| 0054A |
|
14 |
14 |
$125.63 |
| 83655 |
|
13 |
13 |
$121.24 |
| 82270 |
|
132 |
130 |
$117.21 |
| 86308 |
|
14 |
13 |
$116.63 |
| 81015 |
|
1,845 |
1,798 |
$104.68 |
| 97116 |
|
17 |
12 |
$99.66 |
| 83020 |
|
13 |
13 |
$85.33 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
601 |
503 |
$77.87 |
| 84157 |
|
15 |
14 |
$77.17 |
| 84300 |
|
26 |
25 |
$71.77 |
| 84479 |
|
595 |
579 |
$65.73 |
| 82542 |
|
12 |
12 |
$64.99 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
76 |
76 |
$55.58 |
| 86922 |
|
14 |
13 |
$43.96 |
| 82340 |
|
12 |
12 |
$27.97 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
109 |
84 |
$20.53 |
| J3490 |
Unclassified drugs |
22 |
22 |
$9.30 |
| 64494 |
|
27 |
27 |
$7.00 |
| 84295 |
|
16 |
13 |
$6.70 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
30 |
29 |
$6.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
17 |
12 |
$5.24 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
13 |
13 |
$3.57 |